Results for:(80 found)
Feb 19, 2013 10:58AM on InvestingBy Jonathan Berr

Next year's games in Sochi may be the most expensive in history, with the tab expected to be 400% more than original projections.

Tags: Sports
Feb 15, 2013 11:28AM on InvestingBy Aimee Picchi

The athletic shoe maker is pulling an ad featuring Olympic runner and alleged murderer Oscar Pistorius. The company seems to have terrible luck with athletes.

Feb 8, 2013 1:13PM on InvestingBy Aimee Picchi

A former promoter is suing the disgraced cyclist, demanding he pay back $12 million in prize money.

Feb 7, 2013 12:05PM on InvestingBy Jonathan Berr

The $6 billion industry needs a strong rebound from last year's disastrous season.

Feb 6, 2013 12:40AM on InvestingBy Bruce Kennedy

Athletes are pushing themselves further to claim the spotlight and the big payouts that come with it. But new concerns are being raised about the risks.

Feb 4, 2013 11:24PM on InvestingBy Bruce Kennedy

There's been a rapid rise in the use of taxpayer money to help finance new and renovated sports venues. But do these projects make good financial sense for the communities involved?

Feb 4, 2013 2:49PM on InvestingBy Jason Notte

Social media lit up during the big game's power outage as companies looked for an edge against competitors.

Feb 4, 2013 1:51PM on InvestingBy Jonathan Berr

A winning quarterback's salty language and a prolonged blackout spoil the Tiffany network's big day.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

TOP STOCKS

This stock is up nearly 300%

Puma Biotechnology shares soar after it says it wants to file for marketing approval of an experimental breast cancer drug.

More

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More